Intelligence · Patents
Patents expiring in 2036
Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.
- Patents
- 1,428
Quick answer
1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9487556
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
granted -
US 9487563
Virus-like particles and methods of use
granted -
US 9487551
Small molecule compounds that control mammal-pathogenic nematodes
granted -
US 9486426
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 9487500
Compounds and compositions thereof
granted -
US 9487485
Method for producing sulfonyl chloride compound
granted -
US 9486518
Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine
granted -
US 9487522
SSH-2 (slingshot-2) inhibitors and methods for making and using them
granted -
US 9487509
Heterocyclic compound
granted -
US 9487508
SGC stimulators
granted -
US 9487511
Cyclopropanamine compound and use thereof
granted -
US 9487493
Use of a PPAR-delta agonist for treating muscle atrophy
granted -
US 9486539
Nipah virus envelope pseudotyped lentiviruses and methods of their use
granted -
US 9486457
Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders
granted -
US 9486414
Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9486401
Use of cellular extracts for skin rejuvenation
granted -
US 9487473
Oligomer-amino acid conjugates
granted -
US 9486451
Abuse resistant pharmaceutical compositions
granted -
US 9486456
Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof
granted -
US 9486446
Orally disintegrating solid preparation
granted -
US 9486424
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 9486481
Method of modulating fatty acid mobilization and oxidation
granted -
US 9486489
Method for producing dry extracts
granted -
US 9487753
Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease
granted -
US 9487780
Antisense compounds targeting genes associated with fibronectin
granted -
US 2016324873
Enzymatic Process for Obtaining 17 Alpha-Monoesters of Cortexolone and/or its 9,11-Dehydroderivatives
granted -
US 9493482
Compounds and methods for preventing or treating sensory hair cell death
granted -
US 9491934
Regulation of endogenous gene expression in cells using zinc finger proteins
granted -
US 9492378
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9492439
Amido compounds as RORγt modulators and uses thereof
granted -
US 9492415
Methods of treating Parkinson's disease using viral vectors
granted -
US 9492430
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
granted -
US 9492433
Pharmaceutical composition for the treatment of Duchenne muscular dystrophy
granted -
US 9492443
Abuse deterrent compositions and methods of making same
granted -
US 9492452
Methods and compositions for inhibition of polymerase
granted -
US 9492477
Compositions comprising citrate and applications thereof
granted -
US 9492490
Pest control using natural pest control agent blends
granted -
US 9492484
Cardiosphere derived cell population and methods of use
granted -
US 9493626
Dispersions comprising discrete carbon nanotube fibers
granted -
US 9492520
Fusion molecule based on novel TAA variant
granted -
US 9492523
Broadly protective Shigella vaccine based on type III secretion apparatus proteins
granted -
US 9492781
Portable oxygen enrichment device and method of use
granted -
US 9493738
Method for producing high yield attenuated Salmonella strains
granted -
US 9492569
Antibodies that bind integrin alpha-V beta-8
granted -
US 9493429
Substituted benzoxazoles and methods of use thereof
granted -
US 9493484
Heterocyclic compound and use thereof
granted -
US 9493467
PI3 kinase antagonists
granted -
US 9493526
Compositions and methods for the delivery of oxygen
granted
Frequently asked questions
How many pharma patents expire in 2036?
1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.